Synthetic dietary inulin, fuji ff, delays development of diet-induced obesity by improving gut microbiota profiles and increasing short-chain fatty acid production
This unique approach not only improves insulin sensitivity and secretion but also aids in reducing appetite, which can be particularly beneficial for clients aiming to achieve weight loss alongside improved glycemic control
Targeted nitric oxide synthase inhibitors for migraine
According to the American Association of Clinical Endocrinologists and American College of Endocrinology (AACE/ACE) Obesity Clinical Practice Guidelines, obese patients receiving incretin-based therapies for weight loss should be monitored for the development of pancreatitis
For patients and prescribers, the practical takeaway is clear: hypersensitivity reactions can occur, but they are usually minor
They serve as a starting point for healthcare providers, researchers, and patients interested in gaining a deeper understanding of these topics